NCT03997734View on ClinicalTrials.gov

Tolerability, Safety and Pharmacokinetics of a Topical AB001 Patch in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 24, 2019

Primary Completion Date

November 11, 2019

Study Completion Date

November 11, 2019

Conditions
Chronic Low Back Pain
Interventions
DRUG

AB001

single and repeated dosing

DRUG

oral capsule

single dose

DRUG

positive comparative patch

single and repeated dosing

DRUG

Placebos

single and repeated dosing

Trial Locations (1)

214041

The Third People's Hospital of Wuxi, Wuxi

Sponsors
All Listed Sponsors
lead

Frontier Biotechnologies Inc.

INDUSTRY